Dr Zhang on the Background of a KEYNOTE-564 Subgroup Analysis in RCC
Tian Zhang, MD, MHS, discusses using the adjuvant KEYNOTE-564 regimen to treat high-risk patients with renal cell carcinoma.
Source: onclive.com
Staging System News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Staging System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Staging System Today - Breaking & Trending Today
Post-Hoc Analysis Supports Adjuvant Pembrolizumab in ccRCC at Increased Risk of Recurrence
Adjuvant pembrolizumab prolonged disease-free survival and distant metastasis–free survival vs placebo in patients with clear cell renal cell carcinoma at increased risk of recurrence after nephrectomy, irrespective of UCLA Integrated Staging System risk category and disease stage.
Source: onclive.com
Patients With Double-Hit Multiple Myeloma Have Inferior Outcomes After Transplant
The presence of 2 or more cytogenetic risk markers is associated with inferior outcomes after transplant in patients with multiple myeloma.
Source: cancertherapyadvisor.com
Ping An AskBob Doctor's Research on Risk Prediction Approach to Tailor Cancer Treatments Published in International Journal JNCI
Press release content from PR Newswire. The AP news staff was not involved in its creation. Ping An AskBob Doctor’s Research on Risk Prediction Approach to Tailor Cancer Treatments Published in International Journal JNCI March 9, 2021 GMT HONG KONG and SHANGHAI, March 9, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An” or the “Group”, HKEX: 2318; SSE: 601318) is pleased to announce that promising research on the artificial intelligence (AI) technology of Ping An AskBob Doctor has been published in The University of Oxford’s Journal of the ...
Source: apnews.com
ESOU 2021: Surgical and Perioperative Challenges of Large Renal Tumors
ESOU 2021: Surgical and Perioperative Challenges of Large Renal Tumors (UroToday.com) At the European Association of Urology (EAU) Section of Oncological Urology (ESOU) 2021 virtual meeting, Dr. Arnaud Mejean discussed surgical and perioperative challenges of large renal tumors, particularly those with vena cava and lymph node involvement. Dr. Mejean notes that statistics from the SEER database suggest that 19% of patients present with locoregional disease, making this an important area of management. Historical data from an international multicenter study shows that based on UCLA Integrate...
Source: urotoday.com